Items where Author is "Hudson, Katie"
Number of items: 5.
HUDSON, Katie, CROSS, Neil, JORDAN-MAHY, Nicola and LEYLAND, Rebecca
(2021).
Investigating the tumour-intrinsic role of programmed death-ligand 1 in 2D and 3D cell culture models of human breast cancer.
In: British Society for Immunology Congress 2021, Edinburgh, UK, 28 Nov - 01 Dec 2021.
(Unpublished)
[Conference or Workshop Item]
HUDSON, Katie, CROSS, Neil, JORDAN-MAHY, Nikki and LEYLAND, Rebecca
(2020).
The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment.
Frontiers in Immunology, 11, p. 568931.
[Article]
HUDSON, Katie, CROSS, Neil, JORDAN-MAHY, Nicola and LEYLAND, Rebecca
(2020).
Blockade of Programmed Death-Ligand 1 with Atezolizumab in Human Breast Cancer 3D Spheroid Colonies Induces Changes in Cell Viability.
In: EACR-AACR-ASPIC Conference: Tumour Microenvironment, Lisbon, Portugal, 02-04 Mar 2020.
European Association for Cancer Research.
(Unpublished)
[Conference or Workshop Item]
HUDSON, Katie, JORDAN-MAHY, Nikki, CROSS, Neil and LEYLAND, Rebecca
(2019).
Programmed death-ligand 1 expression in human cancer cell lines in two-dimensional and three-dimensional cell culture systems.
In: BACR: Tumour Microenvironment meeting, Nottingham, UK, 01-03 Jul 2019.
British Association for Cancer Research.
(Unpublished)
[Conference or Workshop Item]
HUDSON, Katie, CROSS, Neil, JORDAN-MAHY, Nicola and LEYLAND, Rebecca
(2018).
Flow cytometric phenotyping of diverse human cancer cell lines for immunological biomarkers expression.
In: BMRC/MERI Winter Poster Event, Sheffield, 14 Dec 2018.
BMRC/MERI.
(Unpublished)
[Conference or Workshop Item]